DFCM
AMRX icon

Dark Forest Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Dark Forest Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-157,954
Closed -$1.99M – 783
2025
Q4 		$1.99M Buy
+157,954
New +$1.81M 0.09% 392
2025
Q3 		– Sell
-159,040
Closed -$1.29M – 1141
2025
Q2 		$1.29M Sell
159,040
-340,667
-68% -$2.57M 0.05% 650
2025
Q1 		$4.19M Buy
499,707
+484,818
+3,256% +$4.05M 0.19% 112
2024
Q4 		$118K Buy
14,889
+754
+5% +$6.33K 0.02% 850
2024
Q3 		$118K Buy
+14,135
New +$111K 0.02% 916

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dark Forest Capital Management's AMRX Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 157,954 shares — an estimated $1.99M sold.

Dark Forest Capital Management first reported a position in AMRX in Q3 2024 and held it in 5 quarters. The position peaked at $4.19M in Q1 2025. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 157,954 Amneal Pharmaceuticals shares in Q1 2026, an estimated $1.99M.
  • Dark Forest Capital Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Dark Forest Capital Management's Amneal Pharmaceuticals position peaked at $4.19M in Q1 2025.
  • 317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.